Literature DB >> 22538214

Association of outer retinal layer morphology with visual acuity in patients with retinal vein occlusion: SCORE Study Report 13.

A Domalpally1, Q Peng, R Danis, B Blodi, I U Scott, M Ip.   

Abstract

PURPOSE: To assess associations between visual acuity (VA) and the status of the photoreceptor inner segment-outer segment (IS-OS) junction in a subset of patients in the Standard Care vs COrticosteroid for REtinal Vein Occlusion (SCORE) Study.
METHODOLOGY: High-resolution time domain optical coherence tomography (OCT) scans of study eyes from a single site participating in the SCORE Study were evaluated. Integrity of the IS-OS junction in the central subfield was evaluated using a three-step scale: absent, abnormal or normal. Associations of the IS-OS status with ETDRS VA letter score and center point thickness (CPT) were investigated.
RESULTS: Baseline OCTs of 42 eyes were evaluated. The IS-OS junction was absent in 30 (71%) and abnormal in 12 (29%). At month 12, the IS-OS junction was absent in 18 (43%), abnormal in 12 (28%), and normal in 12 (28%) eyes. At baseline, IS-OS status was significantly associated with CPT, but not with VA. At month 12, IS-OS status was significantly associated with CPT and VA, that is, absent or abnormal IS-OS was associated with increased CPT and worse VA. Change in IS-OS status was not associated with change in CPT (P=0.8). Worsening of IS-OS status was associated with loss of VA and improvement in IS-OS status to normal was associated with gain in VA (P=0.03).
CONCLUSION: In this data set with long-term follow-up of OCTs as part of the SCORE Study, there is a correlation between change in IS-OS status and VA. This supports further evaluation of outer retinal morphology in larger data sets.

Entities:  

Mesh:

Year:  2012        PMID: 22538214      PMCID: PMC3396161          DOI: 10.1038/eye.2012.59

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  31 in total

1.  Associations between macular findings by optical coherence tomography and visual outcomes after epiretinal membrane removal.

Authors:  Min Hee Suh; Jong Mo Seo; Kyu Hyung Park; Hyeong Gon Yu
Journal:  Am J Ophthalmol       Date:  2008-12-03       Impact factor: 5.258

2.  Correlation between retinal sensitivity and photoreceptor inner/outer segment junction in patients with retinitis pigmentosa.

Authors:  Y Mitamura; S Aizawa; T Baba; A Hagiwara; S Yamamoto
Journal:  Br J Ophthalmol       Date:  2009-01       Impact factor: 4.638

3.  Correlation of visual recovery with presence of photoreceptor inner/outer segment junction in optical coherence images after epiretinal membrane surgery.

Authors:  Y Mitamura; K Hirano; T Baba; S Yamamoto
Journal:  Br J Ophthalmol       Date:  2008-10-29       Impact factor: 4.638

4.  A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5.

Authors:  Michael S Ip; Ingrid U Scott; Paul C VanVeldhuisen; Neal L Oden; Barbara A Blodi; Marian Fisher; Lawrence J Singerman; Michael Tolentino; Clement K Chan; Victor H Gonzalez
Journal:  Arch Ophthalmol       Date:  2009-09

5.  Automated 3-D intraretinal layer segmentation of macular spectral-domain optical coherence tomography images.

Authors:  Mona Kathryn Garvin; Michael David Abràmoff; Xiaodong Wu; Stephen R Russell; Trudy L Burns; Milan Sonka
Journal:  IEEE Trans Med Imaging       Date:  2009-03-10       Impact factor: 10.048

6.  SCORE Study report 3: study design and baseline characteristics.

Authors:  Michael S Ip; Neal L Oden; Ingrid U Scott; Paul C VanVeldhuisen; Barbara A Blodi; Maria Figueroa; Andrew Antoszyk; Michael Elman
Journal:  Ophthalmology       Date:  2009-07-19       Impact factor: 12.079

7.  A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6.

Authors:  Ingrid U Scott; Michael S Ip; Paul C VanVeldhuisen; Neal L Oden; Barbara A Blodi; Marian Fisher; Clement K Chan; Victor H Gonzalez; Lawrence J Singerman; Michael Tolentino
Journal:  Arch Ophthalmol       Date:  2009-09

8.  Association between foveal photoreceptor integrity and visual outcome in neovascular age-related macular degeneration.

Authors:  Hisako Hayashi; Kenji Yamashiro; Akitaka Tsujikawa; Masafumi Ota; Atsushi Otani; Nagahisa Yoshimura
Journal:  Am J Ophthalmol       Date:  2009-03-27       Impact factor: 5.258

9.  SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion.

Authors:  Ingrid U Scott; Paul C VanVeldhuisen; Neal L Oden; Michael S Ip; Barbara A Blodi; J Michael Jumper; Maria Figueroa
Journal:  Ophthalmology       Date:  2009-01-22       Impact factor: 12.079

10.  Comparison of reflectivity maps and outer retinal topography in retinal disease by 3-D Fourier domain optical coherence tomography.

Authors:  Maciej Wojtkowski; Bartosz L Sikorski; Iwona Gorczynska; Michalina Gora; Maciej Szkulmowski; Danuta Bukowska; Jakub Kaluzny; James G Fujimoto; Andrzej Kowalczyk
Journal:  Opt Express       Date:  2009-03-02       Impact factor: 3.894

View more
  9 in total

Review 1.  Mechanisms of vision loss in eyes with macular edema associated with retinal vein occlusion.

Authors:  Hiroyuki Iijima
Journal:  Jpn J Ophthalmol       Date:  2018-03-23       Impact factor: 2.447

2.  ELLIPSOID ZONE MAPPING AND OUTER RETINAL CHARACTERIZATION AFTER INTRAVITREAL OCRIPLASMIN.

Authors:  Yuji Itoh; Justis P Ehlers
Journal:  Retina       Date:  2016-12       Impact factor: 4.256

3.  Intravitreal bevacizumab injections for diabetic macular edema - predictors of response: a retrospective study.

Authors:  Lavnish Joshi; Asaf Bar; Oren Tomkins-Netzer; Satish Yaganti; Jiten Morarji; Panayiotis Vouzounis; Sophie Seguin-Greenstein; Simon R Taylor; Sue Lightman
Journal:  Clin Ophthalmol       Date:  2016-10-21

4.  Analysis of Morphologic and Functional Outcomes in Macular Edema due to Central Retinal Vein Occlusion Treated with Intravitreal Dexamethasone Implant.

Authors:  Alfredo Niro; Giancarlo Sborgia; Alessandra Sborgia; Luigi Sborgia; Claudio Furino; Nicola Recchimurzo; Giovanni Alessio
Journal:  J Ophthalmol       Date:  2018-09-09       Impact factor: 1.909

5.  Initial dose of three monthly intravitreal injections versus PRN intravitreal injections of bevacizumab for macular edema secondary to branch retinal vein occlusion.

Authors:  Seong Joon Ahn; Jeeyun Ahn; Se Joon Woo; Kyu Hyung Park
Journal:  Biomed Res Int       Date:  2013-08-26       Impact factor: 3.411

6.  Comparison of the efficacy and safety of drug therapies for macular edema secondary to central retinal vein occlusion.

Authors:  Tianwei Qian; Mengya Zhao; Yongjing Wan; MengXiao Li; Xun Xu
Journal:  BMJ Open       Date:  2018-12-28       Impact factor: 2.692

7.  Evaluation of the Initial Optical Coherence Tomography Parameters in Anticipating the Final Visual Outcome of Central Retinal Vein Occlusion.

Authors:  Muhammet Derda Ozer; Muhammed Batur; Selma Mesen; Serek Tekin; Erbil Seven
Journal:  J Curr Ophthalmol       Date:  2020-03-23

8.  Automated Quantification of Photoreceptor alteration in macular disease using Optical Coherence Tomography and Deep Learning.

Authors:  José Ignacio Orlando; Bianca S Gerendas; Sophie Riedl; Christoph Grechenig; Anna Breger; Martin Ehler; Sebastian M Waldstein; Hrvoje Bogunović; Ursula Schmidt-Erfurth
Journal:  Sci Rep       Date:  2020-03-27       Impact factor: 4.379

9.  Comparison between blue-on-yellow and white-on-white perimetry in patients with branch retinal vein occlusion.

Authors:  Kunihiro Azuma; Tatsuya Inoue; Ryosuke Fujino; Nozomi Igarashi; Shotaro Asano; Yoko Nomura; Yohei Hashimoto; Keiko Azuma; Ryo Asaoka; Kazuaki Kadonosono; Ryo Obata
Journal:  Sci Rep       Date:  2020-11-17       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.